Abstract
Therapy-refractory supraventricular tachycardias commonly result in hydrops and death in human fetuses. Fetal transesophageal electrocardiography may aid in understanding its underlying electrophysiological mechanism and allow stimulation. Percutaneous fetoscopic deployment of an electrode catheter into the fetal esophagus by way of a single trocar was performed in a human fetus and permitted the recording of a fetal transesophageal electrocardiogram at 35 + 6 weeks of gestation. Fetal transesophageal electrocardiography can be achieved in human fetuses by way of a minimally invasive percutaneous fetoscopic approach and carries the potential to improve diagnosis and management of therapy-refractory supraventricular tachycardias in human fetuses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
